v3.26.1
Medtronic Agreement (Details) - USD ($)
3 Months Ended 6 Months Ended
Aug. 28, 2025
Aug. 04, 2025
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Jul. 31, 2025
Medtronic Agreement                
Aggregate purchase price       $ 5,855,000        
Public Offering                
Medtronic Agreement                
Additional shares to be purchased 2,182,500              
Medtronic, Inc.                
Medtronic Agreement                
Reimbursable research and development expense     $ 2,800,000   $ 4,000,000 $ 5,400,000 $ 7,400,000  
Revenue recognized to date     $ 0     0    
Medtronic, Inc. | Series D-2 Preferred Stock                
Medtronic Agreement                
Proceeds from issuance of Series D-2 Preferred Stock           40,000,000    
Medtronic, Inc. | Private Placement | Related Party                
Medtronic Agreement                
Shares issued (in shares) 132,282 4,077,427            
Share issue price (in dollars per share) $ 2.75 $ 2.75            
Aggregate purchase price $ 363,775 $ 11,200,000            
Medtronic, Inc. | Loan Agreement | Secured Subordinated Convertible Promissory Note (the "Notes")                
Medtronic Agreement                
Term loan               $ 20,000,000
Minimum | Medtronic, Inc.                
Medtronic Agreement                
Expected to receive product price           500    
Maximum | Medtronic, Inc.                
Medtronic Agreement                
Expected to receive product price           1,600    
Location, Statement of Financial Position, Activity, Accrual [Axis]: us-gaap:AccruedLiabilitiesCurrent | Medtronic, Inc.                
Medtronic Agreement                
Reimbursable research and development expense           $ 4,500,000